Human mesenchymal stem cells (hMSCs) are multipotent cells that can differentiate into many cell types. Chondrogenesis is induced in hMSCs cultured as a micromass pellet to mimic cellular condensation during cartilage development, and exposed to transforming growth factor b (TGFb). Interestingly, TGFb can also induce hMSC differentiation to smooth-muscle-like cell types, but it remains unclear what directs commitment between these two lineages. Our previous work revealed that cell shape regulates hMSC commitment between osteoblasts and adipocytes through RhoA signaling. Here we show that cell shape also confers a switch between chondrogenic and smooth muscle cell (SMC) fates. Adherent and well-spread hMSCs stimulated with TGFb3 upregulated SMC genes, whereas cells allowed to attach onto micropatterned substrates, but prevented from spreading and flattening, upregulated chondrogenic genes. Interestingly, cells undergoing SMC differentiation exhibited little change in RhoA, but significantly higher Rac1 activity than chondrogenic cells. Rac1 activation inhibited chondrogenesis and was necessary and sufficient for inducing SMC differentiation. Furthermore, TGFb3 and Rac1 signaling upregulated N-cadherin, which was required for SMC differentiation. These results demonstrate a chondrogenic-SMC fate decision mediated by cell shape, Rac1, and N-cadherin, and highlight the tight coupling between lineage commitment and the many changes in cell shape, cell-matrix adhesion, and cell-cell adhesion that occur during morphogenesis. STEM CELLS 2010;28:564-572 Disclosure of potential conflicts of interest is found at the end of this article.
INTRODUCTION
Human mesenchymal stem cells (hMSCs) can differentiate into several cell types, including osteoblasts, adipocytes, chondrocytes, and myocytes [1] . Like many stem cells, hMSCs differentiate into distinct lineages depending on which cues are present in the local tissue microenvironment. While much effort has focused on identifying soluble differentiation factors to mimic these cues, investigators only recently have begun to appreciate the potential importance of insoluble signals such as cell adhesion, cell shape, mechanical forces, and substrate rigidity in stem cell differentiation [2] [3] [4] .
During morphogenesis, cells undergo dramatic changes in cell shape as they differentiate into different lineages. Osteogenic cells initially take on a flattened morphology as they begin to calcify matrix, whereas chondrogenic and adipogenic cells round up in their early differentiation, and myogenic cells extend into elongated spindles to execute their muscular functions. It has largely been thought that these structural changes are a consequence of differentiation programs. However, several studies have noted that changes in cell shape itself can regulate the differentiation of mesenchymal progenitor cells. For example, fibronectin-induced cell flattening and spreading inhibits the adipogenic differentiation of 3T3-F442A preadipocytes, which can be reversed by keeping cells in a round configuration or upon disruption of the cytoskeleton [5] . Similarly, chondrocytes taken from condensed articular cartilage and allowed to attach on a planar substrate downregulate chondrocyte-specific markers [6] . In contrast, controlled cell spreading enhances differentiation in preosteoblastic progenitors [7] . Our previous work extended the osteogenic-adipogenic axis to hMSCs, identifying cell shape as an important regulator in hMSC commitment between an osteogenic or adipogenic fate [3] .
Although accumulating data suggest a role for cell shape in many important biologic processes such as cell division [8] , apoptosis [9] , nuclear organization [10] , morphogenesis [11] , and differentiation [12, 13] , the molecular basis of these cell shape-mediated effects has not been fully understood. It is well known that Rho family small GTPases can regulate cell shape through modulating cytoskeleton [14] . Interestingly, it has been shown that cell shape may also affect the activity of Rho GTPases [15] . Our previous work demonstrated that cell shape can regulate RhoA activity, and that this activity mediates the shape-dependent control of hMSC lineage commitment to osteoblasts or adipocytes [3] . These studies indicate a role for Rho family GTPase signaling in early cellular developmental processes.
In vitro chondrogenesis of MSCs is induced when cells are cultured as a high density micromass pellet, which mimics cellular condensation during cartilage development, and exposed to transforming growth factor b (TGFb) [1, 16] . Interestingly, it has been shown that TGFb also induces differentiation of hMSCs to smooth muscle-like cell types in vitro [17, 18] , but it remains unclear what additional factors determine the TGFb-induced commitment to a chondrogenic versus smooth muscle cell (SMC) lineage. While it has been assumed that the initial lack of cell-matrix adhesion and presence of cell-cell adhesion likely contribute to the chondrogenic effects of pellet culture, we hypothesized that cell shape plays an important role in regulating TGFb-induced hMSC differentiation to chondrogenic versus SMC fate. Using a micropatterning technique to control cell shape and degree of cell spreading, we found that hMSCs allowed to attach onto micropatterned substrates, but prevented from spreading and flattening, upregulated chondrogenic genes in response to TGFb3 stimulation, whereas cells allowed to spread on substrates underwent SMC differentiation, supporting the idea that cell shape confers a switch between chondrogenic and myogenic potential. We further showed that cells undergoing SMC differentiation versus chondrogenesis exhibited little change in RhoA activity but significantly higher Rac1 activity during differentiation. This cell shape-dependent Rac1 activation was required for SMC differentiation and inhibited chondrogenesis, and further regulated changes in N-cadherin expression that appear to be also required for robust SMC differentiation. Thus, the many structural changes in cells that occur during morphogenesis may in fact play direct regulatory roles in modulating the differentiation of stem cells to appropriate tissue lineages.
MATERIALS AND METHODS

Cell Culture and Reagents
Human mesenchymal stem cells were obtained from Lonza and maintained in growth medium (Dulbecco's modified Eagle's medium [DMEM] containing 10% fetal bovine serum, 0.3 mg/ml glutamine, 100 lg/ml streptomycin, 100 units/ml penicillin). Only early passage hMSCs (passage 4-6) were used for experimental studies. No difference was observed among these passages. For chondrogenic and smooth muscle cell differentiation, hMSCs were cultured in serum-free incomplete differentiation media (Lonza, hMSC Differentiation BulletKit -chondrogenic, cat#PT-3003, Walkersville, MD, http://www.lonzabio.com/) supplemented with 10 ng/ml TGFb3 (Sigma) in pelleted form or on tissue culture plates (at 3,000 cells/cm 2 unless specified otherwise), respectively. Pellet cultures were prepared according to protocol (Lonza). Briefly, 2.5 Â 10 5 cells per pellet were transferred into 15 ml polypropylene tubes and centrifuged at 150g for 5 minutes at room temperature. Then the pellets were rinsed with incomplete differentiation medium (without TGFb3), centrifuged and resuspended in complete differentiation medium (with TGFb3). The cells were centrifuged again and the pellets were incubated at 37 C with 5% carbon dioxide. Media were changed every 3 days.
Fabrication of Micropatterned Substrates
Micropatterned substrates were prepared per Tan et al. [19] . In brief, polydimethylsiloxane (PDMS) stamps were cast, baked, and removed from master templates, which were previously created using photolithographic methods. Stamps were coated with fibronectin (25 lg/ml; BD biosciences, San Jose, CA, http:// www.bdbiosciences.com/) for 2 hours, washed with water, and dried with compressed nitrogen. Flat PDMS substrates were UV oxidized for 7 minutes (UVO cleaner 342, Jelight Co., Irvine, CA, http://www.jelight.com/), stamped with fibronectin, blocked with Pluronic F127 for 1 hour, and rinsed three times with phosphate buffered saline before cell seeding. Substrates without features (flat substrate), with 100 Â 100 lm (10,000 lm 2 ) islands, or with 32 Â 32 lm (1,024 lm 2 ) islands were prepared.
Cell Differentiation Assay
Human mesenchymal stem cells were cultured in growth medium (GM) 
Immunohistology and Immunofluorescence
Pelleted cells were fixed with 3.7% formaldehyde, embedded in paraffin, processed, and sectioned according to standard histopathologic protocols (Johns Hopkins Surgical Pathology). Sections were deparaffinized using xylene followed by a graded alcohol series, and stained with Alcian blue. Cells grown on plates or patterns were either fixed with 4% paraformaldehyde and permeabilized with 0.2% Triton X-100, or fixed and permeabilized with À20 C methanol: acetone (1:1), blocked with 33% goat serum, incubated with primary antibodies, and followed by Alex 594-conjugated anti-smooth muscle (Molecular Probes Inc., Eugene, OR, http:// probes.invitrogen.com). The primary antibodies were obtained as follows: antismooth muscle a (Sigma), anti-calponin (DAKO, Glostrup, Denmark, http://www.dako.com), anti-collagen II (MP Biomedicals, Irvine CA, http://www.mpbio.com). Cell nuclei were stained with 4 0 ,6-diamidino-2-phenylindole (DAPI). Cells were visualized using a Nikon Eclipse TE200.
Differential Interference Contrast Microscopy
Differential interference contrast (DIC) microscopy images of hMSC on patterns were acquired using Zeiss AxioVert200M. Images were shade-corrected per [20] .
Real-Time RT-PCR
Total RNA was isolated using an RNeasy Micro kit (Qiagen, Hilden, Germany, http://www1.qiagen.com) according to the manufacturer's instructions. Complementary DNA (cDNA) was transcribed with Oligo-dT primers using Moloney Murine Leukemia Virus (MMLV) reverse transcriptase (Invitrogen, Carlsbad, CA, http://www.invitrogen.com) with 0.5 lg of total RNA per reaction. Quantitative polymerase chain reaction (PCR) was performed in an ABI 7,300 system (Applied BioSystems, Foster City, CA, http://www.appliedbiosystems.com) using TaqMan gene expression assays according to the manufacturer's instructions. Results were analyzed using the relative quantitation method, and all mRNA expression data were normalized to GAPDH expression in the corresponding sample and then to the control sample. All data are represented as mean 6 SEM; n ! 3. TaqMan gene expression assays used were as follows: ACTA2 (Hs00426835_g1); CNN1 (Hs00154543_m1); SMTN (Hs00199489_m1); MYOCD (Hs00538076_m1); SOX9 (Hs001 65814_m1); COL2A1 (Hs00264051_m1); OPGL (Hs00243 522_m1); SOX5 (Hs00374709_m1); SOX6 (Hs00264525_m1); CALD (Hs00263998_m1); SM22 (Hs00162558_m1); MYH11 (Hs00224610_m1); MYOD (Hs00159528_m1). sulfate polyacrylamide gel electrophoresis, and electroblotted onto polyvinylidene fluoride membrane (PVDF), blocked with 5% dry milk in TBST, immunoblotted with specific primary antibodies and horseradish peroxidase (HRP)-conjugated secondary antibodies (Jackson Laboratory, Bar Harbor, ME, http://www.jax. org), and detected by enhanced chemiluminescence (ECL) (Pierce Chemical Co.). Protein levels were quantified using a Versadoc imaging system (Bio-Rad Laboratories). The antibodies were obtained as follows: anti-a-tubulin (Sigma); anti-N-cadherin (BD Transduction Laboratories, BD biosciences, San Jose, CA, http:// www.bdbiosciences.com/); anti/smooth muscle a (DakoCytomation, Glostrup, Denmark, http://www.dakocytomation.com); anticalponin anti-smooth muscle a (Sigma); anti-Rac1 (Upstate, Millipore, Billerica, MA, http://www.millipore.com). All data are represented as mean 6 SEM; n ! 3.
Rho GTPase Assay
RhoA-GTP loading was measured by either pull-down assay as previously described [3] or G-LISA RhoA Activation Assay (Cytoskeleton, Denvor, CO, http://www.cytoskeleton.com/) per the manufacturer's instructions.
Rac GTPase Assay
Rac1-GTP loading was measured by either pull-down assay using a commercially available kit (Upstate) or G-LISA Rac Activation Assay (Cytoskeleton) according to the manufacturers' instructions. Pak1-PBD beads were used as supplied and also made using GST-tagged recombinant Pak1-PBD produced in BL21 cells containing the pGEX-PBD vector (a gift from L. Romer, Johns Hopkins University, Baltimore, MD). Protein levels were detected by Western blot and quantified using a Versadoc imaging system (Bio-Rad Laboratories).
Lentivirus Production
The cDNAs of EGFP, EGFP-RacV12 (constitutively active mutant of Rac1 fused to EGFP), and EGFP-RacN17 (dominant negative mutant of Rac1 fused to EGFP) (gifts from M. Philips, NY University Medical Center, New York, NY) were subcloned into the pRRL-cPPT-CMV-X2-PRE-SIN vector and then cotransfected with pMDLg/pRRE, pCMV-VSVG and pRSV-REV packaging vectors (gifts from W. Osborne, University of Washington, Seattle, WA) into Ad293 cells using Lipofectamine 2000 (Invitrogen). Viral supernatants were collected after 48 hours, centrifuged at 1,500rpm for 5 minutes, filtered through a 0.45 lm filter (Nalgene, Rochester, NY, http://www.nalgenunc.com), aliquoted, and stored at À80
C. Viral titer was determined by serial dilution and infection of hMSCs. Cells were infected in the presence of 10 lg/ml polybrene. The titer giving >90% transduction efficiency (by examining the percentage of green fluorescent protein (GFP)-positive cells) and minimum cell death was used.
Recombinant Adenovirus Construction
The cDNA fragment encoding human N-cadherin lacking 105 bps (base pairs) at the C-terminus (the b-catenin-binding domain) was amplified by PCR from full length N-cadherin (a gift from B. McKay, University of Arizona) using forward primer GAGGCGGCCGCACCATGTGCCGGATAGCGGGA and reverse primer GAGC TCGAGTCAGCTCAAGGACCCAGCAGT, and was cloned into pShuttle-IRES-hrGFP-1 using NotI/XhoI sites. Recombinant adenoviruses were prepared using the AdEasy XL system (Stratagene, La Jolla, CA, http://www.stratagene.com/) as previously described [21] .
Measurement of the Spreading Area of hMSCs
MSCs were transduced with low titer lentivirus expressing GFP so that only about 10% of cells were infected. Fluorescent images of infected cells were taken and areas were measured with AxioVision software. About 30 cells were measured for each condition and data were averaged across three independent experiments.
Statistical Analysis
Statistical analysis was performed by Student's t test, one-way analysis of variance (ANOVA), or two-way ANOVA. Tukey's honestly significant difference test was used for pairwise comparisons. Sample sizes and data analysis specific to individual experiments are indicated in the associated text or figure legends.
RESULTS
Cell Shape Regulates hMSC Differentiation into Smooth Muscle Cells Versus Chondrocytes
When grown as micromass pellets in a chondrogenic differentiation medium containing TGFb3 for 7 days, hMSCs underwent chondrogenesis in culture as indicated by Alcian blue staining for glycosaminoglycans and real-time RT-PCR analysis of chondrogenic markers (Fig. 1A, 1B , supporting information Fig. S1 ), as has been also reported by others [1] . Interestingly, when these same cells were plated on tissue culture dishes at subconfluent density (3,000 cell/cm 2 ) in the same differentiation medium, smooth muscle cell (SMC) but not chondrogenic markers were rapidly upregulated (Fig. 1A, 1C ). The upregulation of SMC gene mRNAs was most robust at 1 day after induction, and then the mRNA expression gradually decreased as the protein expression increased and peaked between 4 to 7 days after induction (supporting information Fig. S2 ). TGFb is the major growth factor present in the differentiation medium critical to MSC chondrogenesis [16, 22] , and we found that TGFb3 alone is also sufficient for upregulating SMC genes (supporting information Fig. S3 ), consistent with previous reports suggesting a role for TGFb in SMC differentiation [17, 18] . However, we did not observe the upregulation of late markers of SMC differentiation such as myosin heavy chain (supporting information Fig. S2 ) even after 14 days of induction, which presumably requires additional factors. In addition, the expression of MyoD1, a skeletal muscle marker, was not detected after 14 days of induction, suggesting hMSCs are not undergoing striated muscle differentiation (supporting information Fig. S2 ). Together, these findings suggest an important role for the differences in culture configuration (pellet versus plate culture) in driving a stem cell fate switch between chondrogenesis and SMC differentiation in the presence of the same soluble cytokines.
It has largely been assumed that the absence of cell-matrix adhesion in the pellet culture acts as a permissive cue for chondrogenesis, but other differences also exist between the chondrogenic and myogenic cultures. We postulated that differences in cell shape, induced in pellet versus plated cultures, may play a role in modulating whether TGFb3 would drive hMSCs toward a chondrogenic versus SMC lineage. To directly examine a role for cell shape in specifying chondrogenic versus SMC fate, we plated hMSCs on polydimethylsiloxane (PDMS) substrates patterned with either small fibronectin islands (1,024 lm 2 ), or large fibronectin islands (10,000 lm 2 ), or unpatterned fibronectin-coated flat regions (spread). Cells on large islands and flat regions attached and spread, while those on small islands were restricted from spreading and maintained a round morphology (Fig. 1D) . Following TGFb3 treatment for 7 days, nearly 40% of cells on large islands and flat regions expressed calponin, a SMC marker, while more than 40% of cells on small islands expressed collagen II, a chondrogenic marker (Fig. 1D) . Realtime RT-PCR analysis showed that SMC and chondrogenic genes were rapidly upregulated (after 1 day of induction) in spread cells and round cells, respectively (Fig. 1E) . These 2 ) or as micromass pellets in growth medium or differentiation medium for 7 days. Cells on plates were fixed and stained for a-smooth muscle (red) and DAPI (blue). Cell pellets were fixed, embedded in paraffin, sectioned, and stained with Alcian blue. Upper panels: bar ¼ 300 lm; lower panels: bar ¼ 50 lm. (B): Real-time PCR analysis of chondrogenic gene expression of hMSCs grown under different culture conditions for 7 days (data are represented as mean 6 SEM; n ¼ 3). Although osteoprotegerin ligand (OPGL) is not commonly used as a chondrogenic marker, we found this gene was specifically and robustly upregulated only during hMSC chondrogenesis (supporting information Fig. S1 ). (C): Real-time PCR analysis of SMC gene expression of hMSCs grown under different culture conditions for 1 day (data are represented as mean 6 SEM; n ¼ 3). (D): Human mesenchymal stem cells were grown on either unpatterned fibronectin-coated PDMS substrate or PDMS substrates patterned with large (10,000 lm 2 ) or small (1,024 lm 2 ) fibronectin islands in GM or DM for 7 days. Cells were fixed, stained for calponin or collagen II (green) and DAPI (blue), and counted (data are represented as mean 6 SEM; n ¼ 3). Bar ¼ 50 lm. (E): Real-time PCR analysis of SMC and chondrogenic gene expression of hMSCs grown on either flat substrate or 1,024 lm 2 islands after 1 day (data are represented as mean 6 SEM; n ¼ 6); *p < .05 and ns (not significant), as calculated by twoway analysis of variance and Tukey's honestly significant difference test. Abbreviations: ACTA2, a-smooth muscle actin; CNN1, calponin 1; COL2A1, collagen II; DAPI, 4 0 ,6-diamidino-2-phenylindole; DM, differentiation medium; GM, growth medium; mRNA, messenger RNA; MYOCD, myocardin; OPGL, osteoprotegerin ligand; SMC, smooth muscle cell (red); SMTN, smoothelin; SOX9, SRY-box 9. results suggested that cell shape indeed regulates hMSC lineage commitment between SMC and chondrogenic fates.
Rac1 Activation Is Necessary and Sufficient for Inducing SMC Differentiation
Prior work described the involvement of RhoA signaling in stem cell commitment [3, 23] . We therefore examined the level of endogenous RhoA activity in hMSCs cultured either at subconfluent density on plates or as micromass pellets, in growth medium as well as differentiation medium. Levels of RhoA activity did not vary substantially among the different culture conditions (Fig. 2A) . Unexpectedly, in screening the activity level of other small GTPases, we discovered that Rac1 activity was significantly higher in well-spread cells during early differentiation than in cells grown as pellets (Fig.  2B, supporting information Fig. S4 ). When cells were grown on patterned substrates in growth medium, spread and unspread cells showed similar levels of Rac1 activity, but exposure to differentiation medium increased Rac1 activity only in the spread cells (Fig. 2C) . These data implicated the involvement of Rac1 and not RhoA in the commitment of hMSCs to smooth muscle cells.
To further examine the role of Rac1, we constructed lentivirus encoding constitutively active (V12) or dominant negative (N17) Rac1 fused to GFP and infected hMSCs prior to plating. The infection of control GFP lentivirus did not promote hMSC SMC differentiation or chondrogenesis in the absence of induction media (growth medium), nor did it inhibit differentiation in the presence of induction media (differentiation medium), compared with non-infected cells (supporting information Fig. S5 ). Interestingly, constitutively active Rac1 induced SMC differentiation when cells were grown in nondifferentiating (growth) medium, whereas dominant negative Rac1 inhibited SMC differentiation when cells were grown in differentiation medium, as seen by real-time PCR analysis of SMC markers at mRNA levels and Western blot at the protein levels (Fig. 2D, 2E ), indicating that Rac1 activity is both necessary and sufficient for inducing hMSC differentiation into the SMC lineage. Conversely, constitutively active Rac1 inhibited chondrogenesis when transduced cells were cultured as pellets in the differentiation medium (Fig. 2F) , though dominant negative Rac1 did not affect chondrogenesis, suggesting that inhibiting Rac1 activity is required, but not sufficient for inducing chondrogenesis.
Because cell shape was previously shown to regulate an adipogenic-osteogenic fate switch in these same hMSCs [3] , we also measured Rac1 activity and the effects of Rac1 mutants during hMSC differentiation into osteoblasts or adipocytes. Moderate (twofold) changes in Rac1 activity were observed during osteogenesis and adipogenesis, respectively (supporting information Fig. S6 ). Under pro-osteogenic conditions, inhibiting Rac1 activity by either dominant negative Rac1 or a small molecule Rac1 inhibitor, NSC23766 (10 lM), suppressed osteogenesis (supporting information Fig. S7A) , and under proadipogenic conditions expressing constitutively active Rac1 inhibited adipogenesis (supporting information Fig. S7B ). Although modulating Rac1 activity could suppress adipogenic or osteogenic fates, these manipulations did not lead to increased adipogenesis or osteogenesis, and they were not sufficient to induce such lineage fates in nondifferentiating growth media (supporting information Fig.  S7C, S7D) . Therefore, unlike RhoA, which is the major regulator in hMSC osteo-and adipo-differentiation, Rac1 seems to play a key role in directing hMSC differentiation into smooth muscle or chondrogenic lineages.
N-Cadherin Expression Is Upregulated During hMSC Differentiation into SMCs
Interestingly, in addition to the effects of increased cell spreading on SMC differentiation, we also observed greater SMC differentiation in hMSCs seeded at increasingly higher densities (Fig. 3A) . When cells were seeded at very low density (1,000 cells/cm 2 ) without cell-cell contacts, we observed that approximately 30% of cells underwent SMC differentiation after 7 days induction (by calponin staining). Meanwhile, 64% of cells underwent SMC differentiation when they were seeded at high density and formed a confluent monolayer (10,000 cells/cm 2 ). Since our previous reports have shown cell spreading to decrease with increasing density [21] , this result appears to contradict a model where increased cell spreading induces SMC differentiation. However, measurements of cell spreading in hMSCs seeded at different densities in the presence of TGFb3 revealed that cells were still wellspread at the highest density examined (10,000 cells/cm 2 ), compared with cells in growth media (supporting information Fig. S8) .
Given that decreased cell spreading was not observed with increasing density in this setting, we explored whether the increased cell-cell contact might be involved in further enhancing SMC differentiation. Cell adhesion molecules such as N-cadherin have been reported to play a role in skeletal muscle and osteoblast differentiation [24, 25] . To examine whether N-cadherin is also involved in hMSC differentiation into SMCs and chondrocytes, we first looked at the N-cadherin expression under different culture conditions. Cells in myogenic conditions (adherent on dishes) showed increased N-cadherin expression, whereas cells cultured as pellets expressed barely detectable levels of N-cadherin (Fig. 3B) . When cells were grown on patterned substrates in growth medium, spread and unspread cells expressed similar levels of N-cadherin, but exposure to differentiation medium increased expression of N-cadherin only in the spread cells (Fig. 3C) , a pattern very similar to Rac1 activation. These data suggested a strong correlation between N-cadherin expression and smooth muscle myogenesis.
N-Cadherin Is Required for TGFb3-and Rac1-Induced SMC Differentiation
To further investigate the role of N-cadherin in hMSC myogenesis, we constructed a recombinant adenovirus expressing the C-terminal cytoplasmic deletion mutant of N-cadherin (ND), which acts as a dominant negative to native N-cadherin (supporting information Fig. S9 ). Expression of ND in hMSCs abrogated TGFb3-induced SMC differentiation (Fig. 4A) . Importantly, cadherin engagement has previously been shown to affect Rac1 activity [24, 26, 27] , and Rac1 signaling has been shown to modulate cadherin-based junction formation [28, 29] . Interestingly, in our system, N-cadherin upregulation appears to be downstream of Rac1 signaling. Constitutively active Rac1, which promoted SMC differentiation, induced an increase in N-cadherin expression in the absence of induction medium (Fig. 4B, 4C ), although it did not promote a further increase of N-cadherin in the induction medium, which might be a result of a self-limiting mechanism to avoid Real-time polymerase chain reaction (PCR) and Western blot analysis of N-cadherin mRNA (1 day) and protein expression (7 days) in hMSCs under different culture conditions. (C): Real-time PCR and Western blot analysis of N-cadherin mRNA (1 day) and protein expression (7 days) in hMSCs grown on either flat substrate or 1,024 lm 2 islands. All data are represented as mean 6 SEM; n ! 3; *p <.05 and ns (not significant) as calculated by two-way analysis of variance and Tukey's honestly significant difference test. Abbreviations: DM, differentiation medium; GM, growth medium; L-GFP, GFP expressing lentivirus; Ad-GFP, GFP expressing adenovirus; L-RacV12, RacV12 expressing lentivirus; Ad-Ndel, Ndel expressing adenovirus; mRNA, messenger RNA; N-cad, N-cadherin; ND, dominant negative N-cadherin mutant; SMC, smooth muscle cell.
overexpression. Conversely, ND had little effect on Rac1 activity in either growth or differentiation medium (Fig. 4D) . Furthermore, Rac1-induced SMC differentiation could be inhibited by ND (Fig. 4E) . These results suggest both TGFb3-and Rac1-induced SMC differentiation are mediated at least partially through N-cadherin.
DISCUSSION
It has been shown that TGFb can induce differentiation of hMSCs to either smooth muscle cells [17, 18] or chondrocytes [1, 16] , depending on their culture configuration. In vitro chondrogenesis is induced when hMSCs are cultured as a micromass pellet and exposed to TGFb, whereas SMC differentiation is induced when hMSCs are cultured as freely spread cells on tissue culture plates and exposed to TGFb. An interesting question thus is how the difference in culture configuration determines TGFb-induced commitment to a chondrogenic versus SMC lineage. We now report that cell shape acts as a key regulator of TGFb3-induced hMSC differentiation to a chondrogenic versus smooth muscle cell fate. By demonstrating a need for pellet culture, previous studies had suggested a role for absence of cell-matrix adhesion in chondrogenesis [16, 30] , but the use of specialized micropatterned substrates here demonstrate the unique importance of cell shape at least in early chondrogenic lineage commitment from the multipotent MSC. Constraining hMSCs to assume a spherical morphology, whether by suspending them in pellet culture or plating onto micropatterned substrates, triggered a chondrogenic fate, while cell adhesion and spreading on plates induced SMC differentiation. Since TGFb has been shown to regulate early steps of smooth muscle cell differentiation during vasculogenesis, it is not surprising that we did not observe the upregulation of late markers of SMC differentiation such as myosin heavy chain even after 14 days of induction (supporting information Fig. S2 ), which presumably requires additional factors. One possibility is that the substrates used in the experiments are not of optimal rigidityboth tissue culture plastics and PDMS ($2.5MPa) have a modulus significantly higher than that of native muscle tissues ($10KPa) and it has been shown that matrix rigidity regulates stem cell lineage specification [2] . Interestingly, the upregulation of chondrogenic genes was much faster in patterned unspread cells (robust expression was detected within 1 day following induction, Fig. 1E ) than in pelleted cells (similar level expression was achieved only after 14 days, supporting information Fig. S1 ), suggesting cells in pellets may need to integrate many more different cues besides cell shape to determine their fate, or they simply experience lower TGFb3 concentrations because of the transport limitation.
Cell shape could regulate the differential responses to TGFb3 through multiple mechanisms. For example, it has been shown that TGFb signaling can be modulated by changes in receptor expression, focal adhesion signaling, and nuclear signaling [31] [32] [33] , each of which could be impacted by cell shape. Changes in cell shape, via rearrangements in the architecture and mechanics of the cytoskeleton, can physically distort the nucleus and alter cell differentiation [7, 34] ; mechanically induce focal adhesion assembly and signaling [35, 36] ; and even directly impact receptor-mediated signaling by altering the spatial distribution of signaling intermediaries relative to the plasma membrane [37] . It would not be surprising that multiple parallel mechanisms are therefore in place for cells to transduce changes in cell shape to drive stem cell fate, especially in settings where such changes in cell shape are themselves important, such as during tissue morphogenesis. Interestingly, cell shape regulation of MSCs is not unique to the chondro-myogenic differentiation axis, as our previous work demonstrated that cell shape in the presence of other (non-TGFb) factors can also regulate stem cell commitment between adipogenic and osteogenic fates [3] . These findings suggest that certain soluble factors can restrict the differentiation potential of MSCs to a subset of lineages (for example, TGFb permitting myogenic and chondrogenic differentiation), whereas shape restricts an orthogonal set (for example, a round shape favoring adipogenesis or chondrogenesis). Together, the combination of soluble and mechanical cues then specifies cell fate.
The Rho GTPases have previously been implicated in regulating stem cell differentiation. Activation of Rho signaling in the p190RhoGAP knockout mouse led to alterations in adipogenesis and myogenesis [23] , and in culture, changes in RhoA signaling have been shown to trigger an adipogenicosteogenic switch in MSC differentiation [3] . In the current study, we demonstrated the importance of another small GTPase, Rac1, in regulating hMSC differentiation into smooth muscle cells or chondrocytes. While Rac1 has been implicated in late stage skeletal myotube fusion [26] , its role in multipotent stem cell commitment has not been widely explored. Both RhoA and Rac1 appear to act as part of a central signaling hub that can integrate adhesive and soluble cues into a specific cellular response-in the context of our studies, lineage specification. Given that hMSCs have potential for yet more lineages, it will be interesting to identify other master regulators. Since cell shape is determined by the cytoskeletal organization and Rho family small GTPases have well established roles in cytoskeleton remodeling, it is not surprising that Rho GTPases are involved in mediating the signals from structural/cytoskeletal changes to cell fate determination.
The intricate link between cell-matrix adhesion, changes in cell shape, and TGFb signaling is further complicated by the observed involvement of N-cadherin in MSC lineage commitment. During skeletal and cardiac muscle differentiation, the interactions between cadherins and Rho GTPases have been shown to play an important role. It has been reported that active RhoA inhibits myoblast fusion by downregulating Mcadherin expression and localization [38] . On the other hand, M-and N-cadherin-dependent adhesion can activate Rac1 which is required for myoblast fusion [26, 24] . Here, we found increased N-cadherin expression downstream of TGFb3 and Rac1 that was required for a much earlier step-MSC commitment to the SMC fate. However, N-cadherin expression may be regulated by additional signaling other than Rac1, since dominant negative Rac1 (RacN17) was not sufficient to inhibit N-cadherin upregulation in the presence of TGFb3 (differentiation medium, Fig. 4B, 4C) . The cytoplasmic domain of N-cadherin is indirectly linked to cytoskeleton via the catenin complex, which consists of at least a-catenin, b-catenin, c-catenin, and p120-catenin [39, 40] . The dominant negative mutant of N-cadherin (ND) used in our study lacks b-catenin binding site, but can still bind to p120-catenin. This mutant changed bcatenin localization from cell-cell junctions and cell membrane to perinuclear regions (supporting information Fig. S9 ). Thus, the inhibitory effect of ND on SMC differentiation may be the result of mislocalization of b-catenin and/or sequestering endogenous p120-catenin. It will be interesting to examine whether b-catenin and/or p120-catenin are involved in TGFb3-induced SMC differentiation. Alternatively, it has been shown that N-cadherin modulates fibroblast growth factor (FGF) receptor signaling [41, 42] and can also negatively regulate Wnt/ b-catenin signaling [43] . It is very likely that crosstalk exists between different pathways.
Interestingly, cadherins are also implicated in other stages of cartilage development. In embryonic limb chondrogenesis, N-cadherin is required for the initial cellular condensation [44] , a process that also involves Rac1 signaling [45] ; during chondrocytic differentiation, however, N-cadherin expression then shuts down [46] . In our studies, we also observed the loss of N-cadherin during hMSC chondrogenesis, but aside from preventing SMC differentiation, the role of this downregulation in chondrogenic commitment remains unclear. It is interesting that N-cadherin and Rac1 signaling are involved in multiple stages in both myogenic and chondrogenic differentiation, perhaps acting as checkpoints to ensure continuous cell-cell contact in the case of myogenic differentiation to produce functional muscle tissue, and to be only transiently required in cartilage development to allow cellular condensation, becoming unnecessary as cells separate into single cells encased in matrix during cartilage tissue formation.
In summary, our results implicate cell shape as an important microenvironmental cue that drives hMSC differentiation into different lineages in response to the same soluble factor. When cells are spread, TGFb3 activates Rac1 and increases N-cadherin expression, which ultimately leads to the upregulation of SMC genes. When cell spreading is restricted, TGFb3 fails to activate Rac1 or increase N-cadherin expression and instead drives induction of chondrogenic genes (Fig.  5 ). These findings demonstrate an intricate link between cell shape, cell-cell adhesion, and TGFb3 signaling, in this case guided by Rac1 signaling. Taken together with our previous findings implicating cell shape and RhoA in driving osteogenic and adipogenic fates, it appears that cells have evolved an elaborate mechanism to integrate adhesive, structural, mechanical, and soluble cues in the microenvironment. Understanding the complex interplay between these cues in different microenvironments is a critical step toward a greater appreciation of how stem cells choose their fates. 
DISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST
The authors indicate no potential conflicts of interest.
